Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody

The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines. A recombinant human antibody to envelope glycoprotein gp120 was generated and used to show that primary isolate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 1994-11, Vol.266 (5187), p.1024-1027
Hauptverfasser: Burton, Dennis R., Pyati, Jayashree, Koduri, Raju, Sharp, Stephen J., Thornton, George B., Paul W. H. I. Parren, Lynette S. W. Sawyer, Hendry, R. Michael, Dunlop, Nancy, Nara, Peter L., Lamacchia, Michael, Garratty, Eileen, Stiehm, E. Richard, Bryson, Yvonne J., Cao, Yunzhen, Moore, John P., Ho, David D., Barbas, Carlos F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1027
container_issue 5187
container_start_page 1024
container_title Science (American Association for the Advancement of Science)
container_volume 266
creator Burton, Dennis R.
Pyati, Jayashree
Koduri, Raju
Sharp, Stephen J.
Thornton, George B.
Paul W. H. I. Parren
Lynette S. W. Sawyer
Hendry, R. Michael
Dunlop, Nancy
Nara, Peter L.
Lamacchia, Michael
Garratty, Eileen
Stiehm, E. Richard
Bryson, Yvonne J.
Cao, Yunzhen
Moore, John P.
Ho, David D.
Barbas, Carlos F.
description The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines. A recombinant human antibody to envelope glycoprotein gp120 was generated and used to show that primary isolates are not refractory to antibody neutralization. The recombinant antibody neutralized more than 75 percent of the primary isolates tested at concentrations that could be achieved by passive immunization, for example, to interrupt maternal-fetal transmission of virus. The broad specificity and efficacy of the antibody implies the conservation of a structural feature on gp120, which could be important in vaccine design.
doi_str_mv 10.1126/science.7973652
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76840402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A15932054</galeid><jstor_id>2885490</jstor_id><sourcerecordid>A15932054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c714t-43afe783fb3308998248e16df370314323da239b99ca1dfe8e711eabcab84db43</originalsourceid><addsrcrecordid>eNqN0s2LEzEUAPBBlLWunr0ozEHEw85uPuYjOdaytoW6FT_2OmYyLyVLJlknGbD-9aZ0qBQKlhwCeb_3CO-9JHmN0TXGpLzxUoOVcF3xipYFeZJMMOJFxgmiT5MJQrTMGKqK58kL7x8QijFOL5KLkU-Sn7dK6V2NkN7BEHph9B8RtLOpU-mXXnei36ZL74wI4Hdvi-V9htNmm4r0K0jXNdqKmLwYOmHTz846aZwVJp3aoBvXbl8mz5QwHl6N92Xy49Pt99kiW63ny9l0lckK5yHLqVBQMaoaShHjnJGcAS5bRStEcU4JbQWhvOFcCtwqYFBhDKKRomF52-T0Mnm_r_vYu18D-FB32kswRlhwg6-rkuUoR-S_EJclzjHjEV7t4UYYqLVVLrZHbsBC7JKzoHR8nuLYUIKK3QeyEzyeFjotT_kPRz6SAL_DRgze18tvd2fT9f3Z9OP8XMrmqyN6dYpKZwxsoI6DnK2P-M2ey95534OqH_ebVGNU79a2Hte2HvcwZrwdhzI0HbQH_y_-bowLL4VRvbBS-wOjlHNEisje7NmDD64_hAljRc4R_Qs5OvqO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16614189</pqid></control><display><type>article</type><title>Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>American Association for the Advancement of Science</source><creator>Burton, Dennis R. ; Pyati, Jayashree ; Koduri, Raju ; Sharp, Stephen J. ; Thornton, George B. ; Paul W. H. I. Parren ; Lynette S. W. Sawyer ; Hendry, R. Michael ; Dunlop, Nancy ; Nara, Peter L. ; Lamacchia, Michael ; Garratty, Eileen ; Stiehm, E. Richard ; Bryson, Yvonne J. ; Cao, Yunzhen ; Moore, John P. ; Ho, David D. ; Barbas, Carlos F.</creator><creatorcontrib>Burton, Dennis R. ; Pyati, Jayashree ; Koduri, Raju ; Sharp, Stephen J. ; Thornton, George B. ; Paul W. H. I. Parren ; Lynette S. W. Sawyer ; Hendry, R. Michael ; Dunlop, Nancy ; Nara, Peter L. ; Lamacchia, Michael ; Garratty, Eileen ; Stiehm, E. Richard ; Bryson, Yvonne J. ; Cao, Yunzhen ; Moore, John P. ; Ho, David D. ; Barbas, Carlos F.</creatorcontrib><description>The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines. A recombinant human antibody to envelope glycoprotein gp120 was generated and used to show that primary isolates are not refractory to antibody neutralization. The recombinant antibody neutralized more than 75 percent of the primary isolates tested at concentrations that could be achieved by passive immunization, for example, to interrupt maternal-fetal transmission of virus. The broad specificity and efficacy of the antibody implies the conservation of a structural feature on gp120, which could be important in vaccine design.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.7973652</identifier><identifier>PMID: 7973652</identifier><identifier>CODEN: SCIEAS</identifier><language>eng</language><publisher>Washington, DC: American Society for the Advancement of Science</publisher><subject>Acquired Immunodeficiency Syndrome - virology ; AIDS ; AIDS vaccines ; AIDS Vaccines - immunology ; AIDS/HIV ; Amino Acid Sequence ; Antibodies ; Antibodies, immunoglobulins ; Antibodies, Monoclonal - immunology ; Antibody Specificity ; Biological and medical sciences ; Enzyme linked immunosorbent assay ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; HIV 1 ; HIV Antibodies - immunology ; HIV Core Protein p24 - analysis ; HIV Envelope Protein gp120 - immunology ; HIV-1 - immunology ; HIV-1 - isolation &amp; purification ; human immunodeficiency virus 1 ; Humans ; Immunization, Passive ; Immunoglobulin Fab Fragments - immunology ; Immunoglobulin G - immunology ; Infant ; Infant, Newborn ; Infants ; Libraries ; Male ; Molecular immunology ; Molecular Sequence Data ; Monoclonal antibodies ; Neutralization Tests ; Reactivity ; Recombinant Proteins - immunology ; Vaccination ; Viruses</subject><ispartof>Science (American Association for the Advancement of Science), 1994-11, Vol.266 (5187), p.1024-1027</ispartof><rights>Copyright 1994 American Association for the Advancement of Science</rights><rights>1995 INIST-CNRS</rights><rights>COPYRIGHT 1994 American Association for the Advancement of Science</rights><rights>COPYRIGHT 1994 American Association for the Advancement of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c714t-43afe783fb3308998248e16df370314323da239b99ca1dfe8e711eabcab84db43</citedby><cites>FETCH-LOGICAL-c714t-43afe783fb3308998248e16df370314323da239b99ca1dfe8e711eabcab84db43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/2885490$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/2885490$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,2884,2885,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3399025$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7973652$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burton, Dennis R.</creatorcontrib><creatorcontrib>Pyati, Jayashree</creatorcontrib><creatorcontrib>Koduri, Raju</creatorcontrib><creatorcontrib>Sharp, Stephen J.</creatorcontrib><creatorcontrib>Thornton, George B.</creatorcontrib><creatorcontrib>Paul W. H. I. Parren</creatorcontrib><creatorcontrib>Lynette S. W. Sawyer</creatorcontrib><creatorcontrib>Hendry, R. Michael</creatorcontrib><creatorcontrib>Dunlop, Nancy</creatorcontrib><creatorcontrib>Nara, Peter L.</creatorcontrib><creatorcontrib>Lamacchia, Michael</creatorcontrib><creatorcontrib>Garratty, Eileen</creatorcontrib><creatorcontrib>Stiehm, E. Richard</creatorcontrib><creatorcontrib>Bryson, Yvonne J.</creatorcontrib><creatorcontrib>Cao, Yunzhen</creatorcontrib><creatorcontrib>Moore, John P.</creatorcontrib><creatorcontrib>Ho, David D.</creatorcontrib><creatorcontrib>Barbas, Carlos F.</creatorcontrib><title>Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines. A recombinant human antibody to envelope glycoprotein gp120 was generated and used to show that primary isolates are not refractory to antibody neutralization. The recombinant antibody neutralized more than 75 percent of the primary isolates tested at concentrations that could be achieved by passive immunization, for example, to interrupt maternal-fetal transmission of virus. The broad specificity and efficacy of the antibody implies the conservation of a structural feature on gp120, which could be important in vaccine design.</description><subject>Acquired Immunodeficiency Syndrome - virology</subject><subject>AIDS</subject><subject>AIDS vaccines</subject><subject>AIDS Vaccines - immunology</subject><subject>AIDS/HIV</subject><subject>Amino Acid Sequence</subject><subject>Antibodies</subject><subject>Antibodies, immunoglobulins</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibody Specificity</subject><subject>Biological and medical sciences</subject><subject>Enzyme linked immunosorbent assay</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>HIV 1</subject><subject>HIV Antibodies - immunology</subject><subject>HIV Core Protein p24 - analysis</subject><subject>HIV Envelope Protein gp120 - immunology</subject><subject>HIV-1 - immunology</subject><subject>HIV-1 - isolation &amp; purification</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Immunization, Passive</subject><subject>Immunoglobulin Fab Fragments - immunology</subject><subject>Immunoglobulin G - immunology</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Libraries</subject><subject>Male</subject><subject>Molecular immunology</subject><subject>Molecular Sequence Data</subject><subject>Monoclonal antibodies</subject><subject>Neutralization Tests</subject><subject>Reactivity</subject><subject>Recombinant Proteins - immunology</subject><subject>Vaccination</subject><subject>Viruses</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0s2LEzEUAPBBlLWunr0ozEHEw85uPuYjOdaytoW6FT_2OmYyLyVLJlknGbD-9aZ0qBQKlhwCeb_3CO-9JHmN0TXGpLzxUoOVcF3xipYFeZJMMOJFxgmiT5MJQrTMGKqK58kL7x8QijFOL5KLkU-Sn7dK6V2NkN7BEHph9B8RtLOpU-mXXnei36ZL74wI4Hdvi-V9htNmm4r0K0jXNdqKmLwYOmHTz846aZwVJp3aoBvXbl8mz5QwHl6N92Xy49Pt99kiW63ny9l0lckK5yHLqVBQMaoaShHjnJGcAS5bRStEcU4JbQWhvOFcCtwqYFBhDKKRomF52-T0Mnm_r_vYu18D-FB32kswRlhwg6-rkuUoR-S_EJclzjHjEV7t4UYYqLVVLrZHbsBC7JKzoHR8nuLYUIKK3QeyEzyeFjotT_kPRz6SAL_DRgze18tvd2fT9f3Z9OP8XMrmqyN6dYpKZwxsoI6DnK2P-M2ey95534OqH_ebVGNU79a2Hte2HvcwZrwdhzI0HbQH_y_-bowLL4VRvbBS-wOjlHNEisje7NmDD64_hAljRc4R_Qs5OvqO</recordid><startdate>19941111</startdate><enddate>19941111</enddate><creator>Burton, Dennis R.</creator><creator>Pyati, Jayashree</creator><creator>Koduri, Raju</creator><creator>Sharp, Stephen J.</creator><creator>Thornton, George B.</creator><creator>Paul W. H. I. Parren</creator><creator>Lynette S. W. Sawyer</creator><creator>Hendry, R. Michael</creator><creator>Dunlop, Nancy</creator><creator>Nara, Peter L.</creator><creator>Lamacchia, Michael</creator><creator>Garratty, Eileen</creator><creator>Stiehm, E. Richard</creator><creator>Bryson, Yvonne J.</creator><creator>Cao, Yunzhen</creator><creator>Moore, John P.</creator><creator>Ho, David D.</creator><creator>Barbas, Carlos F.</creator><general>American Society for the Advancement of Science</general><general>American Association for the Advancement of Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>IBG</scope><scope>IOV</scope><scope>ISN</scope><scope>7QO</scope><scope>7T5</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19941111</creationdate><title>Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody</title><author>Burton, Dennis R. ; Pyati, Jayashree ; Koduri, Raju ; Sharp, Stephen J. ; Thornton, George B. ; Paul W. H. I. Parren ; Lynette S. W. Sawyer ; Hendry, R. Michael ; Dunlop, Nancy ; Nara, Peter L. ; Lamacchia, Michael ; Garratty, Eileen ; Stiehm, E. Richard ; Bryson, Yvonne J. ; Cao, Yunzhen ; Moore, John P. ; Ho, David D. ; Barbas, Carlos F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c714t-43afe783fb3308998248e16df370314323da239b99ca1dfe8e711eabcab84db43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Acquired Immunodeficiency Syndrome - virology</topic><topic>AIDS</topic><topic>AIDS vaccines</topic><topic>AIDS Vaccines - immunology</topic><topic>AIDS/HIV</topic><topic>Amino Acid Sequence</topic><topic>Antibodies</topic><topic>Antibodies, immunoglobulins</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibody Specificity</topic><topic>Biological and medical sciences</topic><topic>Enzyme linked immunosorbent assay</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>HIV 1</topic><topic>HIV Antibodies - immunology</topic><topic>HIV Core Protein p24 - analysis</topic><topic>HIV Envelope Protein gp120 - immunology</topic><topic>HIV-1 - immunology</topic><topic>HIV-1 - isolation &amp; purification</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Immunization, Passive</topic><topic>Immunoglobulin Fab Fragments - immunology</topic><topic>Immunoglobulin G - immunology</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Libraries</topic><topic>Male</topic><topic>Molecular immunology</topic><topic>Molecular Sequence Data</topic><topic>Monoclonal antibodies</topic><topic>Neutralization Tests</topic><topic>Reactivity</topic><topic>Recombinant Proteins - immunology</topic><topic>Vaccination</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burton, Dennis R.</creatorcontrib><creatorcontrib>Pyati, Jayashree</creatorcontrib><creatorcontrib>Koduri, Raju</creatorcontrib><creatorcontrib>Sharp, Stephen J.</creatorcontrib><creatorcontrib>Thornton, George B.</creatorcontrib><creatorcontrib>Paul W. H. I. Parren</creatorcontrib><creatorcontrib>Lynette S. W. Sawyer</creatorcontrib><creatorcontrib>Hendry, R. Michael</creatorcontrib><creatorcontrib>Dunlop, Nancy</creatorcontrib><creatorcontrib>Nara, Peter L.</creatorcontrib><creatorcontrib>Lamacchia, Michael</creatorcontrib><creatorcontrib>Garratty, Eileen</creatorcontrib><creatorcontrib>Stiehm, E. Richard</creatorcontrib><creatorcontrib>Bryson, Yvonne J.</creatorcontrib><creatorcontrib>Cao, Yunzhen</creatorcontrib><creatorcontrib>Moore, John P.</creatorcontrib><creatorcontrib>Ho, David D.</creatorcontrib><creatorcontrib>Barbas, Carlos F.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Gale In Context: Biography</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Canada</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burton, Dennis R.</au><au>Pyati, Jayashree</au><au>Koduri, Raju</au><au>Sharp, Stephen J.</au><au>Thornton, George B.</au><au>Paul W. H. I. Parren</au><au>Lynette S. W. Sawyer</au><au>Hendry, R. Michael</au><au>Dunlop, Nancy</au><au>Nara, Peter L.</au><au>Lamacchia, Michael</au><au>Garratty, Eileen</au><au>Stiehm, E. Richard</au><au>Bryson, Yvonne J.</au><au>Cao, Yunzhen</au><au>Moore, John P.</au><au>Ho, David D.</au><au>Barbas, Carlos F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>1994-11-11</date><risdate>1994</risdate><volume>266</volume><issue>5187</issue><spage>1024</spage><epage>1027</epage><pages>1024-1027</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><coden>SCIEAS</coden><abstract>The ability of antibodies to neutralize diverse primary isolates of human immunodeficiency virus-type 1 in vitro has been questioned, with implications for the likely efficacy of vaccines. A recombinant human antibody to envelope glycoprotein gp120 was generated and used to show that primary isolates are not refractory to antibody neutralization. The recombinant antibody neutralized more than 75 percent of the primary isolates tested at concentrations that could be achieved by passive immunization, for example, to interrupt maternal-fetal transmission of virus. The broad specificity and efficacy of the antibody implies the conservation of a structural feature on gp120, which could be important in vaccine design.</abstract><cop>Washington, DC</cop><pub>American Society for the Advancement of Science</pub><pmid>7973652</pmid><doi>10.1126/science.7973652</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 1994-11, Vol.266 (5187), p.1024-1027
issn 0036-8075
1095-9203
language eng
recordid cdi_proquest_miscellaneous_76840402
source MEDLINE; JSTOR Archive Collection A-Z Listing; American Association for the Advancement of Science
subjects Acquired Immunodeficiency Syndrome - virology
AIDS
AIDS vaccines
AIDS Vaccines - immunology
AIDS/HIV
Amino Acid Sequence
Antibodies
Antibodies, immunoglobulins
Antibodies, Monoclonal - immunology
Antibody Specificity
Biological and medical sciences
Enzyme linked immunosorbent assay
Fundamental and applied biological sciences. Psychology
Fundamental immunology
HIV 1
HIV Antibodies - immunology
HIV Core Protein p24 - analysis
HIV Envelope Protein gp120 - immunology
HIV-1 - immunology
HIV-1 - isolation & purification
human immunodeficiency virus 1
Humans
Immunization, Passive
Immunoglobulin Fab Fragments - immunology
Immunoglobulin G - immunology
Infant
Infant, Newborn
Infants
Libraries
Male
Molecular immunology
Molecular Sequence Data
Monoclonal antibodies
Neutralization Tests
Reactivity
Recombinant Proteins - immunology
Vaccination
Viruses
title Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A28%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficient%20Neutralization%20of%20Primary%20Isolates%20of%20HIV-1%20by%20a%20Recombinant%20Human%20Monoclonal%20Antibody&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Burton,%20Dennis%20R.&rft.date=1994-11-11&rft.volume=266&rft.issue=5187&rft.spage=1024&rft.epage=1027&rft.pages=1024-1027&rft.issn=0036-8075&rft.eissn=1095-9203&rft.coden=SCIEAS&rft_id=info:doi/10.1126/science.7973652&rft_dat=%3Cgale_proqu%3EA15932054%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16614189&rft_id=info:pmid/7973652&rft_galeid=A15932054&rft_jstor_id=2885490&rfr_iscdi=true